Literature DB >> 8595907

The murine biglycan: complete cDNA cloning, genomic organization, promoter function, and expression.

Y Wegrowski1, J Pillarisetti, K G Danielson, S Suzuki, R V Iozzo.   

Abstract

Biglycan is a ubiquitous chondroitin/dermatan sulfate proteoglycan that belongs to a growing family of proteins harboring leucine-rich repeats. We have cloned and sequenced the cDNA containing the complete murine biglycan, elucidated its genomic organization, and demonstrated functional promoter activity of its 5' flanking region. The deduced biglycan protein core was highly conserved across species. However, the mouse biglycan (Bgn) gene was significantly larger than the human counterpart, primarily because of a large > 4.5-kb intron between exons 1 and 2. The mouse Bgn gene spanned over 9.5 kb of continuous DNA and comprised 8 exons, with a perfectly conserved intron/exon organization vis-á-vis the human counterpart. The promoter region was enriched in GC dinucleotide and contained numerous cis-acting elements including binding sites for SP-1, AP-1 and AP-2 factors. It lacked TATA and CAAT boxes typical of housekeeping genes. In support of this, primer extension analysis showed the existence of multiple transcription start sites. Transient cell transfection assays with a construct comprising the 548 bp upstream of the major transcription start site fused to the chloramphenicol acetyl transferase reporter gene showed functional promoter activity. Internal and 5' deletion constructs showed that the distal promoter of the Bgn gene was required for full transcriptional activity. In contrast to the homologous proteoglycan decorin, the highest expression of biglycan mRNA was observed in lung, liver, and spleen of adult mouse and the lowest in skin, heart, and kidney. These results will be useful for the study of biglycan gene regulation and for the generation of mice with targeted null mutation of the Bgn gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595907     DOI: 10.1006/geno.1995.0002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  [A comparison of the gene expression patterns of human chondrocytes and chondrogen differentiated mesenchymal stem cells for tissue engineering].

Authors:  U R Goessler; P Bugert; K Bieback; S Bag; H Sadick; H Klüter; K Hörmann; F Riedel
Journal:  HNO       Date:  2006-04       Impact factor: 1.284

2.  Immortalized, cloned mouse chondrocytic cells (MC615) produce three different matrix proteoglycans with core-protein-specific chondroitin/dermatan sulphate structures.

Authors:  R Kokenyesi; J E Silbert
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Modulation of sulfated glycosaminoglycan and small proteoglycan synthesis by the extracellular matrix.

Authors:  Y Wegrowski; P Gillery; G Kotlarz; C Perreau; N Georges; F X Maquart
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

4.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

5.  The gene structure and organization of mouse PG-Lb, a small chondroitin/dermatan sulphate proteoglycan.

Authors:  Y Iwata; T Shinomura; K Kurita; M Zako; K Kimata
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Modulation of canonical Wnt signaling by the extracellular matrix component biglycan.

Authors:  Agnes D Berendsen; Larry W Fisher; Tina M Kilts; Rick T Owens; Pamela G Robey; J Silvio Gutkind; Marian F Young
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

7.  Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases.

Authors:  Guang Dai; Till Freudenberger; Petra Zipper; Ariane Melchior; Susanne Grether-Beck; Berit Rabausch; Jens de Groot; Sören Twarock; Helmut Hanenberg; Bernhard Homey; Jean Krutmann; Julia Reifenberger; Jens W Fischer
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

8.  Presence of pro-forms of decorin and biglycan in human articular cartilage.

Authors:  P J Roughley; R J White; J S Mort
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  Characterization of the human proline/arginine-rich end leucine-rich repeat protein (PRELP) gene promoter and identification of a repressor element.

Authors:  J Grover; P J Roughley
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

10.  Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis.

Authors:  Thomas O McDonald; Ross G Gerrity; Christy Jen; Hao-Ji Chen; Kathleen Wark; Thomas N Wight; Alan Chait; Kevin D O'Brien
Journal:  J Histochem Cytochem       Date:  2007-07-24       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.